TEARDX, LLC

Medtech · Private

Point-of-care diagnostic test for rapid detection of ocular herpes infections using an ocular sampling tool and assay

Grants
$275K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
7
2 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Point-of-Care Detection of HSV-1 Keratitis using Minimally Invasive Ocular Inserts$275,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1694INTEGUMED, LLC——
1695ZBEATS, INC.——
1696MOLECULAR SURFACE TECHNOLOGIES LLC——
1697TEARDX, LLC——
1698ONTOGEN MEDTECH——
1699Amnio Technology, LLC—$50K
1700PASCALL Systems, Incorporated——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 7
  • Anti-fogging Facemaskgranted
  • Ocular Inserts With Protease Sensing Indicatorsapplication
  • Anti-fogging Facemaskapplication
  • Ocular Devices And Methods For The Employment Thereofgranted
  • Ocular Inserts With Analyte Capture And Release Agentsapplication
  • Ocular Inserts With Analyte Capture And Release Agentsapplication
  • Ocular Devices And Methods For The Employment Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.